PLRX · Pliant Therapeutics, Inc.
Market Cap
$68.73M
Shares
61.92M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-01-22 | MICHAEL OUIMETTE | Officer | 10,230 | 2025-01-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-03 | JOHANNES P HULL | Officer | 34,919 | 2023-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-07-20 | MICHAEL OUIMETTE | Officer | 4,755 | 2023-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1746473
CUSIP
729139105
13F (30d)
84 filings
82 filers
Visit website
Investor relations